Zimmer Biomet
NYSE ZBH · Warsaw, IN
Works in Cardiovascular · Dermatology · Genetic & rare · Immunology · Metabolic & endocrine · Musculoskeletal · Neurology · Oncology · Ophthalmology · Respiratory
Zimmer Biomet is a clinical trial sponsor based in Warsaw, IN, listed as NYSE ZBH. It has 62 active clinical trials with 14,380 planned participants, across 10 therapeutic areas. Since 2021 it has completed 64 trials and stopped 38 early.
Trial track record · since 2021
Financials · NYSE ZBH
Pipeline · 62 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Zimmer Biomet
Zimmer Biomet is lead sponsor of 62 active clinical trials on ClinicalTrials.gov, with 14,380 planned participants, in Cardiovascular, Dermatology, Genetic & rare, Immunology and other areas. Since 2021 it has completed 64 trials and stopped 38 early.
Zimmer Biomet is based in Warsaw, IN and is listed as NYSE ZBH. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Zimmer Biomet; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-16.
Approve Suite is not affiliated with Zimmer Biomet.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.